Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

TCT 2015: Heartflow’s FFR CT Could Bring Costs Down By One-Third

This article was originally published in Clinica

Executive Summary

HeartFlow’s FFR CT imaging system has demonstrated that it can pare off over 30% of the average cost of treating symptomatic patients at intermediate risk of coronary disease, while improving their quality of life. Experts who have reviewed the data from a cost and quality-of-life analysis of the PLATFORM trial caution, however, that this result will have to be confirmed in large randomized trials before FFR CT imaging supplants other types of noninvasive testing.

Advertisement

Related Content

£9m NHS Savings With HeartFlow 'Virtual FFR' Gets NICE Nod

Topics

Advertisement
UsernamePublicRestriction

Register

MT102924

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst

Cancel